Latest filing published 03 May 2024 for Telesis Bio Inc..
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Annette Tumolo: trading record in brief
Annette Tumolo (chief executive) discloses dealings in 2 companies, chiefly Bio-Rad Laboratories, Inc. and Telesis Bio Inc. In total, 62 filings cover trades dated from 5 September 2018 to 1 May 2024.
The open-market record consists of 12 sales worth €6.0M, with no purchase. Besides market trades, the filings include 22 share grants and 27 option exercises.
Most recently, on 3 May 2024, the filings show a share grant in Telesis Bio Inc. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Annette Tumolo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 46,752 shares0Common StockSEC:0000950170-24-053135:0
- 74,611 shares0Common StockSEC:0001209191-22-043010:0
- 613 shares@ US$333.3430.5% of flowBio-Rad A Common StockSEC:0001062993-21-010826:0
- 600 shares0Bio-Rad A Common StockSEC:0001062993-21-008416:0
- 557 shares0Bio-Rad A Common StockSEC:0001062993-21-008352:0
- 433 shares0Bio-Rad A Common StockSEC:0001062993-21-008254:0
- 600 shares@ US$792.5869.5% of flowBio-Rad A Common StockSEC:0001062993-21-007992:0
7 of 7 declarations
